Table of Contents

Article

• You have access

  Development and clinical application of COX-2–selective inhibitors for the treatment of osteoarthritis and rheumatoid arthritis

  Clifton O. Bingham, MD

  Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 1) SI-5-SI-12;
• You have access

  Cyclooxygenase-2–selective inhibitors: Translating pharmacology into clinical utility

  Bruce N. Cronstein, MD

  Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 1) SI-13-SI-19;
• You have access

  COX-2–selective inhibitors in the treatment of arthritis

  Thomas J. Schnitzer, MD, PhD and Marc C. Hochberg, MD, MPH

  Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 1) SI-20-SI-30;
• You have access

  Gastrointestinal safety and tolerability of non-selective non-steroidal anti-inflammatory agents and cyclooxygenase-2–selective inhibitors

  David A. Peura, MD

  Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 1) SI-31-SI-39;
• You have access

  Outcomes studies of the gastrointestinal safety of cyclooxygenase-2 inhibitors

  James M. Scheiman, MD

  Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 1) SI-40-SI-46;
• You have access

  Current perspective on the cardiovascular effects of coxibs

  Marvin A. Konstam, MD and Matthew R. Weir, MD

  Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 1) SI-47-SI-52;
• You have access

  Renal effects of nonselective NSAIDs and coxibs

  Matthew R. Weir, MD

  Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 1) SI-53-SI-58;
• You have access

  Developing an economic rationale for the use of selective COX-2 inhibitors for patients at risk for NSAID gastropathy

  A. Mark Fendrick, MD

  Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 1) SI-59-SI-64;
• You have access

  Cyclooxygenase-2–selective inhibitors in the management of acute and perioperative pain

  Warren A. Katz, MD

  Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 1) SI-65-SI-75;
• You have access

  Emerging options with coxib therapy

  Mark J. Lema, MD, PhD

  Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 1) SI-76-SI-84;